La Jolla re-evaluates its development of LJPC-401 due to mixed clinical results Nov. 27, 2019 No Comments
Preliminary clinical data on CRISPR/Cas9 gene-editing therapy CTX-001 in severe hemoglobinopathies Nov. 20, 2019 No Comments
FDA approves Adakveo to reduce vaso-occlusive crises in patients with sickle cell disease Nov. 18, 2019 No Comments
Sansheng's clinical trial application for HIF-117 capsules cleared in China Nov. 15, 2019 No Comments
Pivotal study of Nucala in hypereosinophilic syndrome meets primary endpoint Nov. 14, 2019 No Comments
FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions Nov. 11, 2019 No Comments
RSS